Key result
Pregnancy altered the phosphorylation state of IGFBP-1, increasing levels measured by RIA 6305 to 37, 51, and 83 micrograms/L across trimesters compared to controls.
Observational
The phosphorylation state of IGFBP-1 changes during pregnancy, which may influence IGF bioavailability and fetal growth.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open whether IGFBP-1 phosphorylation changes affect fetal growth.
We have determined the phosphorylation pattern of circulating insulin-like growth factor-binding protein-1 (IGFBP-1) in normal subjects and assessed how this changes in pregnancy. Two RIAs employing different monoclonal antibodies (MAbs 6303 or 6305) were used to measure IGFBP-1. In normal subjects, RIA 6303 measured 11-fold higher levels than RIA 6305 (72.8 vs. 6.6 micrograms/L; P < 0.008). However, in amniotic fluid (AF), the two assays gave similar results. Immunoprecipitation of plasma and AF with MAb 6303 and 6305 before nonsodium dodecyl sulfate-electrophoresis and Western ligand blotting revealed different IGFBP-1 isoforms and differential antibody recognition as the cause of this discrepancy. In AF, both MAbs precipitated nonphosphorylated and phosphorylated isoforms, whereas in plasma, only a single highly phosphorylated species, not seen in AF, was observed. This form of IGFBP-1 was precipitated by MAb 6303 only. During pregnancy, the phosphorylation state of IGFBP-1 in the maternal circulation was altered, as nonphosphorylated IGFBP-1 and three lesser phosphoforms were also observed. The appearance of these other variants resulted in a significant increase in IGFBP-1 measured by RIA 6305 (37, 51, and 83 micrograms/L in first, second, and third trimesters, respectively; P < 0.0005 vs. controls). The changes in IGFBP-1 phosphorylation induced by pregnancy may influence the modulatory effects of IGFBP-1 on IGF bioavailability and, hence, fetal growth.
No takes yet. Share an insight, caveat, or question.
Westwood et al. (1994) conducted an observational in Pregnancy. Pregnancy vs. Normal subjects was evaluated on IGFBP-1 levels measured by RIA 6305 (p=<0.0005). Pregnancy altered the phosphorylation state of IGFBP-1, increasing levels measured by RIA 6305 to 37, 51, and 83 micrograms/L across trimesters compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: